Pfizer Sells £3 Billion of Shares in Sensodyne Maker Haleon
Pfizer Inc. has sold over £3 billion ($3.8 billion) of shares in Haleon Plc, the first step by the UK consumer health company’s biggest shareholder to reduce its 32% stake.
Pfizer Inc. has sold over £3 billion ($3.8 billion) of shares in Haleon Plc, the first step by the UK consumer health company’s biggest shareholder to reduce its 32% stake.
The yen weakened after the Bank of Japan brought an end to the world’s last negative interest-rate policy and emphasized that financial conditions will remain easy.
Bitcoin extended a retreat as investors digested a record daily outflow from the world’s biggest exchange-traded fund for the token as well as scaled-back expectations for Federal Reserve interest-rate cuts.
Robinhood Markets Inc.’s commission free trading is now available throughout the UK — though the company said an effort to add margin lending to the offering is on pause.
Emmanuel Macron pledged to make Paris a haven for capital markets with a fresh round of measures that would facilitate initial public offerings and direct more investment to smaller companies.
{{ video.ContentPackages[0].ScheduleStartDateTime | fromNow }}
{{ currentStream.Desc }}